Early Administration of Tirofibanin Mid- to High-risk Patients with Non-ST Elevation Acute Coronary Syndrome Referred for Elective Percutaneous Coronary Intervention (ETN-STEP): A Multi-center Randomized Controlled Clinical Trial in China

Early Administration ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Elective Percutaneous Coronary Intervention ◽

Percutaneous Coronary ◽

Risk Patients ◽

Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled clinic trial in Chinese patients

Journal of Geriatric Cardiology ◽

10.3724/sp.j.1263.2012.02272 ◽

2013 ◽

Vol 9 (4) ◽

pp. 375-378 ◽

Author(s):

Li Jian-Ping ◽

Liu Qun ◽

Huo Yong

Keyword(s):

Acute Coronary Syndrome ◽

Coronary Intervention ◽

Chinese Patients ◽

Early Administration ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Risk Patients ◽

Anti-Oxidative Stress Effect of Loading-Dose Rosuvastatin Prior to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Prospective Randomized Controlled Clinical Trial

Clinical Drug Investigation ◽

10.1007/s40261-014-0231-0 ◽

2014 ◽

Vol 34 (11) ◽

pp. 773-781 ◽

Cited By ~ 8

Author(s):

Dong Liang ◽

Qian Zhang ◽

Hexu Yang ◽

Ran Zhang ◽

Wei Yan ◽

...

Keyword(s):

Oxidative Stress ◽

Clinical Trial ◽

Coronary Intervention ◽

Stress Effect ◽

Loading Dose ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

BMC Cardiovascular Disorders ◽

10.1186/s12872-018-0938-6 ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Wonjae Lee ◽

Jung-Won Suh ◽

Jin Joo Park ◽

Chang-Hwan Yoon ◽

Young-Seok Cho ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Acute Coronary Syndrome ◽

Controlled Trial ◽

Coronary Intervention ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

St Elevation ◽

Elevation Acute Coronary Syndrome

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial

Trials ◽

10.1186/1745-6215-14-62 ◽

2013 ◽

Vol 14 (1) ◽

pp. 62 ◽

Author(s):

Dong-Hyun Lee ◽

Moo Hyun Kim ◽

Tae-Ho Park ◽

Jong Sung Park ◽

Kyungil Park ◽

...

Keyword(s):

Clinical Trial ◽

Study Protocol ◽

Platelet Reactivity ◽

Coronary Intervention ◽

High Platelet Reactivity ◽

Randomized Controlled ◽

Effect of Danlou Tablet (丹蒌片) on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-015-2284-1 ◽

2015 ◽

Vol 21 (9) ◽

pp. 662-666 ◽

Cited By ~ 5

Author(s):

Lei Wang ◽

Shuai Mao ◽

Jian-yong Qi ◽

Yi Ren ◽

Xin-feng Guo ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Myocardial Injury ◽

Controlled Trial ◽

Coronary Intervention ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Multicenter Randomized Controlled Trial ◽

St Elevation ◽

Danlou Tablet

GLYCOPROTEIN IIB/IIIA INHIBITORS WITH UPSTREAM OR DOWNSTREAM THIENOPYRIDINE USE IMPROVE OUTCOMES AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN HIGH RISK PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION- A METAREGRESSION OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(12)60261-7 ◽

2012 ◽

Vol 59 (13) ◽

pp. E260

Author(s):

Ankur Sethi ◽

Anurag Bajaj ◽

Amol Bahekar ◽

Rohit Bhuriya ◽

Param Singh ◽

...

Keyword(s):

Myocardial Infarction ◽

High Risk ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Risk Patients ◽

The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent

Data in Brief ◽

10.1016/j.dib.2016.12.019 ◽

2017 ◽

Vol 10 ◽

pp. 518-524 ◽

Cited By ~ 2

Author(s):

Cristina Lucía Dávila-Fajardo ◽

Jesús Sánchez-Ramos ◽

Xando Diaz- Villamarín ◽

Luis Javier Martínez-González ◽

Pablo Toledo Frías ◽

...

Keyword(s):

Clinical Trial ◽

Study Protocol ◽

Coronary Intervention ◽

Randomized Controlled ◽

Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction-a meta-regression of randomized controlled trials

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.24653 ◽

2013 ◽

Vol 82 (2) ◽

pp. 171-181 ◽

Cited By ~ 16

Author(s):

Ankur Sethi ◽

Anurag Bajaj ◽

Amol Bahekar ◽

Rohit Bhuriya ◽

Mukesh Singh ◽

...

Keyword(s):

Myocardial Infarction ◽

High Risk ◽

Coronary Intervention ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Risk Patients ◽

St Elevation ◽

Meta Regression

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. A randomized controlled clinical trial

ACC Current Journal Review ◽

10.1016/s1062-1458(02)00947-9 ◽

2002 ◽

Vol 11 (6) ◽

pp. 66 ◽

Author(s):

P.W.J.C. Serruys ◽

P. de Feyter ◽

C. Macaya

Keyword(s):

Clinical Trial ◽

Coronary Intervention ◽

Cardiac Events ◽

Randomized Controlled ◽

TCT-846 Early versus Delayed Percutaneous Coronary Intervention for High Risk patients with Non ST Elevation-Acute Coronary Syndrome: A Meta-analysis.

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2013.08.1600 ◽

2013 ◽

Vol 62 (18) ◽

pp. B255

Author(s):

Naveen Rajpurohit ◽

Colin Farritor ◽

Muhammad Khan ◽

Tom P. Stys ◽

Marian Petrasko ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

High Risk ◽

Meta Analysis ◽

Coronary Intervention ◽

High Risk Patients ◽

Coronary Syndrome ◽

Percutaneous Coronary ◽

Risk Patients ◽